retatrutide phase 3 results october 2025 Lilly's triple agonist delivers up to 71.2 lbs of weight loss Eli Lilly's Phase 3 data

Our meals feature clean, responsibly sourced proteinfrom grass-fed beef, free-range poultry, and wild-caught seafood to plant-based powerhouses like tofu, black beans, Daring Chicken, and Impossible

The most common effects are mild nausea, upset stomach, bloating, and changes in bowel habits, especially when starting or raising the dose

10.1111/dom.13761 Summary Keywords anti-inflammatory, atherosclerosis, coronary artery disease, glucagon-like peptide-1, mechanisms Citation Skrobucha A, Pindlowski P, Krajewska N, Grabowski M and Jonik S (2024) Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review

With GLP-1 drugs, the goal for nutrition has shifted from calorie restriction to calorie quality

Monitoring thyroid function more closely during the first few months of Retatrutide treatment and adjusting levothyroxine doses as needed ensures continued adequate thyroid hormone levels